Corvus Pharmaceuticals

Filed a patent for "methods for treating renal cell carcinoma" on Tue, December 27, 2022

Filed a patent for "itk inhibitors for increasing th1 cell activity" on Fri, October 21, 2022

Filed a patent for "anti-cd73 compounds to treat oncovirus-positive cancers" on Thu, November 2, 2023

Filed a patent for "itk inhibitors for increasing th1 cell activity" on Tue, April 5, 2022